SCYNEXIS, Inc. Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights
SCYNEXIS, Inc. (SCYX) reported Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights of 273.20 thousand shares for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights · last filed 2014-08-13
- SCYNEXIS, Inc. incremental common shares attributable to participating nonvested shares with non-forfeitable dividend rights for the quarter ending 2014-06-30 was 273.20K shares.
- SCYNEXIS, Inc. incremental common shares attributable to participating nonvested shares with non-forfeitable dividend rights for the quarter ending 2014-03-31 was 274.99K shares.
- SCYNEXIS, Inc. incremental common shares attributable to participating nonvested shares with non-forfeitable dividend rights for the quarter ending 2013-06-30 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights 3 month | Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights 6 month |
|---|---|---|
| 2014-06-30 | 273.20K shares 10-Q · filed 2014-08-13 | 273.71K shares 10-Q · filed 2014-08-13 |
| 2014-03-31 | 274.99K shares 10-Q/A · filed 2014-07-11 | |
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-13 | 0.00 shares 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |